VISIE Inc. Innovates with Continuous Anatomic Auto Tracking
In a significant advancement for robotic-assisted surgeries, VISIE Inc. has announced a groundbreaking technology known as Continuous Anatomic Auto Tracking (CAAT) designed to enhance total knee arthroplasty procedures. This innovation was introduced at their headquarters in Austin, showcasing their commitment to pushing the boundaries of orthopedic surgery.
Understanding Continuous Anatomic Auto Tracking
Continuous Anatomic Auto Tracking, or CAAT, is an impressive technological development that empowers surgical robotic systems, specifically tailored for orthopedic applications like robotic-assisted total knee arthroplasty. With this new capability, VISIE's technology allows for real-time tracking of the structures involved in knee joint movement.
Advantages of CAAT in Surgery
The main function of CAAT is to provide 3D scanners with the ability to continuously monitor the motion of the distal femur and proximal tibia. This remarkable feature is designed to enhance surgical precision by ensuring that robotic surgical arms operate in direct correlation with the anatomical movements of the knee, thus improving the overall surgical experience.
The Impact on Robotic-Assisted Surgery
As the demand for high-precision techniques in surgery rises, CAAT could pave the way for significant shifts in the future of robotic-assisted techniques. If surgeons have access to robotic systems equipped with vision-like capabilities, it would revolutionize their practice, promoting increased safety and efficiency.
Expert Insights on CAAT
Leading orthopedic surgeon J. Craig Morrison, MD, spoke on CAAT's potential, stating, "Having robotic systems that can observe the anatomy similar to the human eye would be transformative, reducing the need for invasive procedures like pin placements. This technology could save time and minimize patient trauma during surgeries."
VISIE's Journey Towards Innovation
VISIE has been diligently testing CAAT to fine-tune its functionality and aims to demonstrate its capabilities at significant conferences, including the American Association of Hip and Knee Surgeons Annual Meeting. Douglas Fairbanks, the CEO of VISIE, expressed overwhelming excitement at showing their achievements to industry leaders.
"Our team continues to push the envelope, achieving breakthrough after breakthrough, and we are ready to transition our focus towards product development for the medical device sector once our demonstrations are completed," stated Michael Landry, VISIE's head of engineering.
Future Prospects of CAAT
While VISIE has not yet submitted the CAAT technology to the FDA, they are enthusiastic about its future and are actively working on validating its performance for anticipated regulatory consideration. Aaron Bernstein, PhD, co-founder and CTO of VISIE, highlighted the broader implications of CAAT beyond knee surgery, mentioning its potential applications across various medical fields, particularly neurosurgery.
A Call for Collaboration and Validation
In the run-up to the upcoming demonstrations, VISIE plans to share insights on their advances at various industry conferences, promoting collaboration and knowledge-sharing. Such engagements include the Digital Orthopaedic Conference and the Musculoskeletal New Ventures Conference. VISIE Inc. is determined to showcase their technology's capabilities and engage with peers and professionals to drive forward the surgical landscape.
About VISIE Inc.
Formerly known as Advanced Scanners, VISIE Inc. is a pioneer in 3D computer vision and spatial computing, specializing in the development of cutting-edge optical scanners for diverse surgical applications. With a strong patent portfolio and numerous awards to their name, VISIE is set to redefine surgical procedures with their innovations.
Frequently Asked Questions
What is Continuous Anatomic Auto Tracking (CAAT)?
CAAT is a revolutionary technology developed by VISIE Inc. that allows robotic systems to continuously track the anatomy of a patient's knee during surgical procedures.
How does CAAT benefit surgeons?
This technology enables robotic arms to move in sync with patients' knee movements, enhancing accuracy and potentially reducing the invasiveness of procedures.
Where will CAAT be demonstrated?
VISIE plans to showcase CAAT at various medical conferences, including the American Association of Hip and Knee Surgeons Annual Meeting and others throughout the year.
Is CAAT currently available for use in surgeries?
As of now, CAAT is still under development and has not been submitted for FDA approval, but VISIE aims to validate its performance for future regulatory submissions.
What specialties could benefit from CAAT technology?
In addition to orthopedic surgeries, CAAT has potential applications in neurosurgery and other medical fields that rely on precise anatomical tracking during operations.
